Invesco Ltd. Dexcom Inc Transaction History

Invesco Ltd.

$453 Billion
Q1 2024

A detailed history of Invesco Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Invesco Ltd. holds 5,574,181 shares of DXCM stock, worth $662 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

5,574,181

Previous 3,543,316 57.32%

Holding current value

$662 Million

Previous $440 Million 75.84%

% of portfolio

0.17%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $232 Million - $285 Million	2,030,865 Added 57.32%	5,574,181 $773 Million
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $223 Million - $368 Million	-2,960,179 Reduced 45.52%	3,543,316 $440 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $36.4 Million - $58.3 Million	422,856 Added 6.95%	6,503,495 $607 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $35.6 Million - $41.4 Million	316,375 Added 5.49%	6,080,639 $781 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $87.8 Million - $104 Million	844,288 Added 17.16%	5,764,264 $670 Million

Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $92.6 Million - $134 Million	1,089,791 Added 28.45%	4,919,976 $557 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $4.53 Million - $5.59 Million	-59,302 Reduced 1.52%	3,830,185 $308 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $184 Million - $359 Million	2,703,328 Added 227.91%	3,889,487 $290 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $18.4 Million - $25.5 Million	195,695 Added 19.76%	1,186,159 $607 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $25.9 Million - $32.4 Million	199,115 Added 25.16%	990,464 $532 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $12.4 Million - $16.6 Million	116,077 Added 17.19%	791,349 $433 Million
Q2 2021 Aug 17, 2021	SELL	$80.99 - $107.93 $32.2 Million - $42.9 Million	-397,383 Reduced 37.05%	675,272 $288 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $5.08 Million - $6.28 Million	59,939 Added 5.92%	1,072,655 $386 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $28 Million - $37.5 Million	-359,298 Reduced 26.19%	1,012,716 $374 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $5.73 Million - $6.77 Million	-59,959 Reduced 4.19%	1,372,014 $566 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $8.33 Million - $14 Million	-132,834 Reduced 8.49%	1,431,973 $581 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $9.12 Million - $14.4 Million	190,862 Added 13.89%	1,564,807 $421 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $6.63 Million - $10.4 Million	181,168 Added 15.19%	1,373,945 $301 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $4.03 Million - $4.97 Million	113,498 Added 10.52%	1,192,777 $178 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $8.13 Million - $11.4 Million	292,180 Added 37.12%	1,079,279 $162 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $10.5 Million - $14.3 Million	-373,311 Reduced 32.17%	787,099 $93.7 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $31.3 Million - $43.4 Million	1,160,410 New	1,160,410 $139 Million

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

352M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $45.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account